FR2329275B1 - - Google Patents

Info

Publication number
FR2329275B1
FR2329275B1 FR7632136A FR7632136A FR2329275B1 FR 2329275 B1 FR2329275 B1 FR 2329275B1 FR 7632136 A FR7632136 A FR 7632136A FR 7632136 A FR7632136 A FR 7632136A FR 2329275 B1 FR2329275 B1 FR 2329275B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7632136A
Other languages
French (fr)
Other versions
FR2329275A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
ICI Americas Inc
ICI United States Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Americas Inc, ICI United States Inc filed Critical ICI Americas Inc
Publication of FR2329275A1 publication Critical patent/FR2329275A1/fr
Application granted granted Critical
Publication of FR2329275B1 publication Critical patent/FR2329275B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7632136A 1975-10-28 1976-10-25 Triazoles substitues Granted FR2329275A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62614075A 1975-10-28 1975-10-28

Publications (2)

Publication Number Publication Date
FR2329275A1 FR2329275A1 (fr) 1977-05-27
FR2329275B1 true FR2329275B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-12-15

Family

ID=24509116

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7632136A Granted FR2329275A1 (fr) 1975-10-28 1976-10-25 Triazoles substitues

Country Status (12)

Country Link
JP (1) JPS5253863A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU1881176A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE847480A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2648826A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK478176A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI763050A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2329275A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL50699A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU76062A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7611944A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO763569L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7611884L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI834666A7 (fi) * 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
CA2015267A1 (en) * 1989-05-26 1990-11-26 Rainer Seele 8-azolylmethylquinolines
SI1501808T1 (sl) 2002-04-26 2008-10-31 Lilly Co Eli Antagonisti tahikininskega receptorja
DE60318697T2 (de) 2002-04-26 2009-01-08 Eli Lilly And Co., Indianapolis Triazolderivate als tachykininrezeptor-antagonisten
WO2005000821A1 (en) * 2003-06-12 2005-01-06 Eli Lilly And Company Tachykinin receptor antagonists
MX374068B (es) 2012-01-26 2020-07-30 Vanda Pharmaceuticals Inc Uso de un agonista de melatonina en el tratamiento de ritmos circadianos de curso libre.
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
WO2014100292A1 (en) 2012-12-18 2014-06-26 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
PT3250563T (pt) 2015-01-30 2022-02-09 Neurocrine Biosciences Inc Triazois substituídos e métodos relacionados aos mesmos
US9771335B2 (en) * 2015-07-31 2017-09-26 The Johns Hopkins University Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels
CN105801499A (zh) * 2016-04-15 2016-07-27 华东理工大学 烯酮制备新型有机oled试剂的设计及其应用
CN111196785B (zh) * 2020-01-21 2021-08-31 成都新朝阳作物科学股份有限公司 三氮唑衍生物及其制备方法和用途

Also Published As

Publication number Publication date
NL7611944A (nl) 1977-05-02
IL50699A0 (en) 1976-12-31
AU1881176A (en) 1978-04-27
FR2329275A1 (fr) 1977-05-27
SE7611884L (sv) 1977-04-29
BE847480A (fr) 1977-04-20
JPS5253863A (en) 1977-04-30
DK478176A (da) 1977-04-29
DE2648826A1 (de) 1977-05-05
LU76062A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-05-18
NO763569L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-04-29
FI763050A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-04-29

Similar Documents

Publication Publication Date Title
FR2327575B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2329275B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2321120B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2337353B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5520213Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5730432Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5422072Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS574363Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS51161199U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5271914U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5261289U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK16975A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5252020U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH600825A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH598738A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE846112A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG21065A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH598372A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH602358A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH601805A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH601658A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH601085A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH600898A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH598138A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH600786A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
ST Notification of lapse